Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA to review potential low testosterone treatment developed by BioSante, licensed to Teva
FDA to review potential low testosterone treatment developed by BioSante, licensed to Teva
FDA to review potential low testosterone treatment developed by BioSante, licensed to Teva
Submitted by
admin
on April 13, 2011 - 10:50am
Source:
Yahoo/AP
News Tags:
BioSante
FDA
testosterone
Teva Pharmaceuticals
Bio-T-Gel
Headline:
FDA to review potential low testosterone treatment developed by BioSante, licensed to Teva
Do Not Allow Advertisers to Use My Personal information
